Raffa Giuseppe Maria, Di Gesaro Gabriele, Sciacca Sergio, Tuzzolino Fabio, Turrisi Marco, Falletta Calogero, Minà Chiara, Romano Giuseppe, Vitale Giuseppe, Panarello Giovanna, Clemenza Francesco, Pilato Michele
Cardiac Surgery and Heart Transplantation Unit, IRCCS - ISMETT (Istituto Mediterraneo per i Trapianti e Terapie ad alta specializzazione), Via Tricomi 5, 90127 Palermo, Italy.
Cardiology Unit, Department for the Treatment and Study of Cardiothoracic Diseases and Cardiothoracic Transplantation, IRCCS - ISMETT (Istituto Mediterraneo per i Trapianti e Terapie ad alta specializzazione), Via Tricomi 5, 90127 Palermo, Italy.
Int J Cardiol. 2016 Sep 15;219:358-61. doi: 10.1016/j.ijcard.2016.06.056. Epub 2016 Jun 17.
Heart transplantation (HTx) improves the quality of life and survival in patients affected by end-stage heart failure. The purpose of the current study is to present the patients' clinical data and results of HTx in a single Center of Sicily. Focus on survival after pre and post HTx mechanical circulatory support use will be performed.
133 HTx were done from 2004 to the end of 2015.The average donor age was 34±13.5years and the proportion of male donors was 67%. Percentage of use of mechanical circulatory support to bridge patients to HTx was 18%.
Overall pre-transplant mechanical circulatory support was not correlated to worse post-transplant prognosis, p=0.757. Severe primary early graft failure requiring extra corporeal membrane oxygenator support strongly impact the early mortality after heart transplantation (p<0.001).
The results of HTx at ISMETT are comparable to those reported in high volume Italian transplant centers as well as in the ISHLT registry. The favorable outcome can be related to focus on multidisciplinary approach, strict recipients' selection and young donor population. Post HTx mechanical circulatory support use in general remains associated with worse post-transplant outcomes. This does not apply to pre-op mechanical circulatory support population.
心脏移植(HTx)可改善终末期心力衰竭患者的生活质量和生存率。本研究的目的是展示西西里岛单一中心心脏移植患者的临床数据和结果。将重点关注心脏移植前后使用机械循环支持后的生存率。
2004年至2015年底共进行了133例心脏移植。供体平均年龄为34±13.5岁,男性供体比例为67%。使用机械循环支持作为患者过渡到心脏移植的比例为18%。
总体而言,移植前机械循环支持与移植后较差的预后无关,p = 0.757。严重的原发性早期移植物功能衰竭需要体外膜肺氧合支持,这对心脏移植后的早期死亡率有强烈影响(p < 0.001)。
ISMETT的心脏移植结果与意大利高容量移植中心以及国际心脏和肺移植协会(ISHLT)登记处报告的结果相当。良好的结果可能与多学科方法、严格的受体选择和年轻的供体群体有关。一般来说,心脏移植后使用机械循环支持仍然与移植后较差的结果相关。这不适用于术前使用机械循环支持的人群。